Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Monika Herian & Paweł Świt. (2023) 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review. Critical Reviews in Toxicology 53:1, pages 15-33.
Read now
Read now
Kyung Sik Yoon, Sun Mi Gu, Hye Jin Cha, Young-Hoon Kim, Jaesuk Yun & Jin-Moo Lee. (2022) 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1. Drug and Chemical Toxicology 45:2, pages 898-906.
Read now
Read now
Fabrizio Schifano, G. Duccio Papanti, Laura Orsolini & John M. Corkery. (2016) Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert Review of Clinical Pharmacology 9:7, pages 943-954.
Read now
Read now
Justin L. Poklis, Carl E. Wolf, Carrol R. Nanco & Alphonse Poklis. (2016) Recommendations for specimen collection for NBOMe analysis in clinical toxicology. Clinical Toxicology 54:2, pages 161-162.
Read now
Read now
Paul Gee, Leo J. Schep, Berit P. Jensen, Grant Moore & Stuart Barrington. (2016) Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases. Clinical Toxicology 54:2, pages 141-146.
Read now
Read now
Sahaphume Srisuma, Alvin C. Bronstein & Christopher O. Hoyte. (2015) NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System. Clinical Toxicology 53:7, pages 624-628.
Read now
Read now
Articles from other publishers (64)
Larissa Marcely Gomes Cassiano, Marina da Silva Oliveira, Wellington Alves de Barros, Ângelo de Fátima & Roney Santos Coimbra. (2023) Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures. Heliyon 9:7, pages e17720.
Crossref
Crossref
Caio H. P. Rodrigues, Lívia S. Mariotto, Jade S. Castro, Paulo H. Peruquetti, Newton C. Silva-Junior & Aline T. Bruni. (2023) Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances. Forensic Toxicology 41:2, pages 187-212.
Crossref
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Crossref
Cheolmin Jo, Hyejin Joo, Dong-Hyun Youn, Jin Mook Kim, Young-Ki Hong, Na Young Lim, Kwan Soo Kim, Su-Jeong Park & Sun Ok Choi. (2022) Rewarding and Reinforcing Effects of 25H-NBOMe in Rodents. Brain Sciences 12:11, pages 1490.
Crossref
Crossref
Klára Šíchová, Kateřina Syrová, Edita Kofroňová, Nikola Pinterova‐Leca, Čestmír Vejmola, Jitka Nykodemová, Petr Palivec, Lucie Olejníková, Hynek Danda, Pascal Jorratt, Šafanda Adam, Bui Quang Hiep, Kristýna Štefková‐Mazochová, Markéta Končická, Martin Kuchař & Tomáš Páleníček. (2022) Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN‐NBOMe. Addiction Biology 27:5.
Crossref
Crossref
Dimitri Gerostamoulos, Linda Glowacki, Maria Pricone, Kerryn Crump, Matthew Di Rago, Samantha Joubert, Matthew J Lynch, Noel W Woodford & Olaf H Drummer. (2022) Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. Journal of Analytical Toxicology.
Crossref
Crossref
Konstantin A. Demin, Olga V. Kupriyanova, Vadim A. Shevyrin, Ksenia A. Derzhavina, Nataliya A. Krotova, Nikita P. Ilyin, Tatiana O. Kolesnikova, David S. Galstyan, Yurii M. Kositsyn, Abubakar-Askhab S. Khaybaev, Maria V. Seredinskaya, Yaroslav Dubrovskii, Raziya G. Sadykova, Maria O. Nerush, Mikael S. Mor, Elena V. Petersen, Tatyana Strekalova, Evgeniya V. Efimova, Savelii R. Kuvarzin, Konstantin B. Yenkoyan, Dmitrii V. Bozhko, Vladislav O. Myrov, Sofia M. Kolchanova, Aleksander I. Polovian, Georgii K. Galumov & Allan V. Kalueff. (2022)
Acute behavioral and Neurochemical Effects of Novel
N
-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish
. ACS Chemical Neuroscience 13:13, pages 1902-1922.
Crossref
Crossref
Tanja M. Gampfer, Lea Wagmann, Benedikt Pulver, Folker Westphal, Veit Flockerzi & Markus R. Meyer. (2022) A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay – Exemplified for nine compounds. Toxicology 476, pages 153258.
Crossref
Crossref
Micaela Tirri, Sabrine Bilel, Raffaella Arfè, Giorgia Corli, Beatrice Marchetti, Tatiana Bernardi, Federica Boccuto, Giovanni Serpelloni, Francesco Botrè, Fabio De-Giorgio, Krystyna Golembiowska & Matteo Marti. (2022) Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs. Frontiers in Psychiatry 13.
Crossref
Crossref
Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L. Smith & Marco Solmi. (2022) Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. International Journal of Environmental Research and Public Health 19:2, pages 915.
Crossref
Crossref
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
279
300
.
Carlos Alberto Yasin Wayhs, Caroline Tortato, Kristiane De Cássia Mariotti, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2021) New Psychoactive Substances Constant State of Flux: NBOMe Brazilian Case. Brazilian Journal of Forensic Sciences, Medical Law and Bioethics 11:1, pages 62-69.
Crossref
Crossref
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Crossref
Wellington Alves de Barros, Marina de Magalhães Silva, Maria Dayanne de Araújo Dantas, Josué Carinhanha Caldas Santos, Isis Martins Figueiredo, Otávio Augusto Chaves, Carlos Mauricio R. Sant’Anna & Ângelo de Fátima. (2021) Recreational drugs 25I-NBOH and 25I-NBOMe bind to both Sudlow's sites I and II of human serum albumin (HSA): biophysical and molecular modeling studies. New Journal of Chemistry 45:29, pages 13158-13167.
Crossref
Crossref
Laura Clancy, Morgan Philp, Ronald Shimmon & Shanlin Fu. (2020) Development and validation of a color spot test method for the presumptive detection of 25‐NBOMe compounds. Drug Testing and Analysis 13:5, pages 929-943.
Crossref
Crossref
F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman & P. Anantha Reddy. (2020) Designer drugs: a medicinal chemistry perspective (II). Annals of the New York Academy of Sciences 1489:1, pages 48-77.
Crossref
Crossref
Katarzyna Kamińska, Paweł Świt & Kamilla Malek. (2020)
2-(4-Iodo-2,5-dimethoxyphenyl)-
N
-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review
. Journal of Analytical Toxicology 44:9, pages 947-956.
Crossref
Crossref
Wellington Alves de Barros, Camila da Silva Nunes, Juliana Alves da Costa Ribeiro Souza, Igor José dos Santos Nascimento, Isis Martins Figueiredo, Thiago Mendonça de Aquino, Leonardo Vieira, Davi Farias, Josué Carinhanha Caldas Santos & Ângelo de Fátima. (2021) The new psychoactive substances 25H-NBOMe and 25H-NBOH induce abnormal development in the zebrafish embryo and interact in the DNA major groove. Current Research in Toxicology 2, pages 386-398.
Crossref
Crossref
Bruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, Frederic Balen, Sébastien Beaune, Régis Bédry, Anthony Chauvin, Isabelle Claudet, Vincent Danel, Guillaume Debaty, Arnaud Delahaye, Nicolas Deye, Jean-Michel Gaulier, Francis Grossenbacher, Philippe Hantson, Frédéric Jacobs, Karim Jaffal, Magali Labadie, Laurence Labat, Jérôme Langrand, Frédéric Lapostolle, Philippe Le Conte, Maxime Maignan, Patrick Nisse, Philippe Sauder, Christine Tournoud, Dominique Vodovar, Sebastian Voicu, Pierre-Géraud Claret & Charles Cerf. (2020) Management of pharmaceutical and recreational drug poisoning. Annals of Intensive Care 10:1.
Crossref
Crossref
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Crossref
Olga V. Kupriyanova, Vadim A. Shevyrin, Yuri M. Shafran, Albert T. Lebedev, Vasili A. Milyukov & Vladimir L. Rusinov. (2020)
Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of
N
‐(2‐methoxybenzyl)‐2‐(dimethoxyphenyl)ethanamine using chromatography–mass spectrometry
. Drug Testing and Analysis 12:8, pages 1154-1170.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Crossref
Fabrizio Schifano, Caroline Zangani, Stefania Chiappini, Amira Guirguis, Stefania Bonaccorso & John M. Corkery. 2020. Violence and Mental Disorders. Violence and Mental Disorders
95
114
.
Jee-Yeon Seo, Kwang-Hyun Hur, Yong-Hyun Ko, Kyungin Kim, Bo-Ram Lee, Young-Jung Kim, Seon-Kyung Kim, Seong-Eon Kim, Yong-Sup Lee, Hyoung-Chun Kim, Seok-Yong Lee & Choon-Gon Jang. (2019) A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents. Brain Research Bulletin 152, pages 19-26.
Crossref
Crossref
João Francisco Allochio Filho, Clebson de Jesus Macrino, Valdemar Lacerda, Marcella Ferreira Rodrigues, Boniek G. Vaz & Wanderson Romão. 2019. Forensic Analytical Methods. Forensic Analytical Methods
198
243
.
Magdalene HY Tang, LY Hung, CK Lai, CK Ching & Tony Wing Lai Mak. (2018) 9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective. Hong Kong Journal of Emergency Medicine 26:3, pages 179-185.
Crossref
Crossref
Ana Maria dos Santos Moreira, Hanna Leijoto de Oliveira, João Francisco Allochio Filho, Diego Hernando Ângulo Florez, Marcela Matos Cordeiro Borges, Valdemar LacerdaJr.Jr., Wanderson Romão & Keyller Bastos Borges. (2019) NBOMe compounds: An overview about analytical methodologies aiming their determination in biological matrices. TrAC Trends in Analytical Chemistry 114, pages 260-277.
Crossref
Crossref
Seo Young Jeon, Young-Hoon Kim, Sung Jin Kim, Soo Kyung Suh & Hye Jin Cha. (2019) Abuse potential of 2-(4-iodo-2, 5-dimethoxyphenyl) N-(2-methoxybenzyl)ethanamine (25I NBOMe); in vivo and ex vivo approaches. Neurochemistry International 125, pages 74-81.
Crossref
Crossref
Peng Xu, Qiyang Qiu, Haijie Li, Sicheng Yan, Mengxiang Yang, C. Benjamin Naman, Youmei Wang, Wenhua Zhou, Haowei Shen & Wei Cui. (2019) 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro. Neurotoxicity Research 35:4, pages 993-998.
Crossref
Crossref
Hyewon Seo, In Sook Kim, Young-Hoon Kim, Hye Hyun Yoo & Jin Hong. (2018) Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry. International Journal of Legal Medicine 133:3, pages 833-841.
Crossref
Crossref
Enrico Gerace, Fabrizio Seganti, Clemente Luciano, Tonia Lombardo, Daniele Di Corcia, Heino Teifel, Marco Vincenti & Alberto Salomone. (2019) On-site identification of psychoactive drugs by portable Raman spectroscopy during drug-checking service in electronic music events. Drug and Alcohol Review 38:1, pages 50-56.
Crossref
Crossref
João Francisco Allochio Filho, Valdemar LacerdaJr.Jr. & Wanderson Romão. 2019. Fundamentals and Applications of Fourier Transform Mass Spectrometry. Fundamentals and Applications of Fourier Transform Mass Spectrometry
469
508
.
Amy J. Eshleman, Katherine M. Wolfrum, John F. Reed, Sunyoung O. Kim, Robert A. Johnson & Aaron Janowsky. (2018) Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors. Biochemical Pharmacology 158, pages 27-34.
Crossref
Crossref
Anne Zwartsen, Laura Hondebrink & Remco HS Westerink. (2018) Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). NeuroToxicology 66, pages 87-97.
Crossref
Crossref
J. Neugarten, B. Friedman & L. Golestaneh. 2018. Comprehensive Toxicology. Comprehensive Toxicology
304
339
.
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Xiongyu Wu, Caroline Eriksson, Ariane Wohlfarth, Jakob Wallgren, Robert Kronstrand, Martin Josefsson, Johan Dahlén & Peter Konradsson. (2017) Synthesis and identification of metabolite biomarkers of 25C-NBOMe and 25I-NBOMe. Tetrahedron 73:45, pages 6393-6400.
Crossref
Crossref
James W. Rajotte, Jean-Paul F.P. Palmentier & Helena Rachelle Wallage. (2017) Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver. Journal of Forensic Sciences 62:5, pages 1410-1413.
Crossref
Crossref
Matthew Valento & Jacob Lebin. (2017) Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones. Clinical Pediatric Emergency Medicine 18:3, pages 203-211.
Crossref
Crossref
Michael B. Gatch, Sean B. Dolan & Michael J. Forster. (2017) Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behavioural Pharmacology 28:5, pages 375-385.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
G Dignam & C Bigham. (2017) Novel psychoactive substances: a practical approach to dealing with toxicity from legal highs. BJA Education 17:5, pages 172-177.
Crossref
Crossref
Line Marie Nielsen, Niels Bjerre Holm, Sebastian Leth-Petersen, Jesper Langgaard Kristensen, Lars Olsen & Kristian Linnet. (2017) Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Testing and Analysis 9:5, pages 671-679.
Crossref
Crossref
Stephen L. Thornton, Sarah Hoehn & Roy R. Gerona. (2017) Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure. Pediatric Emergency Care, pages 1.
Crossref
Crossref
Ana Flávia B. AndradeSamuel Kasahun MamoJose Gonzalez-Rodriguez. (2017) Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry. Analytical Chemistry 89:3, pages 1445-1452.
Crossref
Crossref
Camille Richeval, Alexandra Boucher, Luc Humbert, Mélodie Phanithavong, Jean-François Wiart, Mustapha Moulsma, Antony Citterio-Quentin, Thierry Coulon, Romain Hernu, Thierry Vial, Delphine Allorge & Jean-Michel Gaulier. (2017) Retrospective identification of 25I-NBOMe metabolites in an intoxication case. Toxicologie Analytique et Clinique 29:1, pages 71-81.
Crossref
Crossref
Sandra Bodeau, Youssef Bennis, Océane Régnaut, Nicolas Fabresse, Camille Richeval, Luc Humbert, Jean-Claude Alvarez, Delphine Allorge & Anne-Sophie Lemaire-Hurtel. (2017) LSD instead of 25I-NBOMe: The revival of LSD? A case report. Toxicologie Analytique et Clinique 29:1, pages 139-143.
Crossref
Crossref
Marek Wiergowski, Justyna Aszyk, Michał Kaliszan, Kamila Wilczewska, Jacek Sein Anand, Agata Kot-Wasik & Zbigniew Jankowski. (2017) Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC–MS/MS in case of severe intoxications. Journal of Chromatography B 1041-1042, pages 1-10.
Crossref
Crossref
Jakob A. Shimshoni, Ilan Winkler, Ezekiel Golan & David Nutt. (2016) Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn-Schmiedeberg's Archives of Pharmacology 390:1, pages 15-24.
Crossref
Crossref
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
283
311
.
Carlos Alberto Yasin Wayhs, Monique dos Reis, Kristiane de Cássia Mariotti, Wanderson Romão, Boniek Gontijo Vaz, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2016) NBOMe: perfil de apreensões da Polícia Federal no Brasil. Revista Brasileira de Criminalística 5:3, pages 22-29.
Crossref
Crossref
Markus R. Meyer. (2016) New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics. Archives of Toxicology 90:10, pages 2421-2444.
Crossref
Crossref
D.M. Wood, B. Ceronie & P.I. Dargan. (2016) Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM 109:8, pages 527-529.
Crossref
Crossref
Marta Rychert & Chris Wilkins. (2016) What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties. Drug Testing and Analysis 8:8, pages 768-778.
Crossref
Crossref
Samantha J. Coward & Hilary J. Hamnett. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
127
146
.
Cristina Miliano, Giovanni Serpelloni, Claudia Rimondo, Maddalena Mereu, Matteo Marti & Maria Antonietta De Luca. (2016) Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience 10.
Crossref
Crossref
Rachel Sutherland, Amy Peacock, Elizabeth Whittaker, Amanda Roxburgh, Simon Lenton, Allison Matthews, Kerryn Butler, Marina Nelson, Lucinda Burns & Raimondo Bruno. (2016) New psychoactive substance use among regular psychostimulant users in Australia, 2010?2015. Drug and Alcohol Dependence 161, pages 110-118.
Crossref
Crossref
Fabrizio Schifano, Laura Orsolini, Duccio Papanti & John Corkery. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
351
380
.
Lysa Remy, Nino Marchi, Juliana Scherer, Tais R. Fiorentin, Renata Limberger, Flavio Pechansky & Felix Kessler. (2015) NBOMe: a new dangerous drug similar to LSD. Revista Brasileira de Psiquiatria 37:4, pages 351-352.
Crossref
Crossref
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
Geoffrey K Isbister, Alphonse Poklis, Justin L Poklis & Jeffrey Grice. (2015) Beware of blotting paper hallucinogens: severe toxicity with NBOMes. Medical Journal of Australia 203:6, pages 266-267.
Crossref
Crossref